Issuance of the sixth series of stock acquisition rights with exercise-price adjustment provisions through a third-party allotment
First written in FY2024. 1 of 3 entries say "Achieved", first in FY2025-H1. Latest entry: FY2025-H1.
24 other companies' latest entry also says "Achieved".
- FY2025-H1AchievedAnnual report
「At a meeting of the board of directors held on 22 July 2024, the company resolved to acquire and cancel all of the 6th Series Stock Acquisition Rights issued through a third-party allotment and carrying provisions for adjustment of the exercise price. On 6 August 2024, it acquired and cancelled all of these stock acquisition rights, totaling 39,637 remaining rights.」
All 39,637 outstanding 6th Series Stock Acquisition Rights were acquired and cancelled on 6 August 2024. The issuance program described in the previous filing was fully cancelled and completed. - FY2025-Q1Updated the use of proceedsAnnual report
「(After the change) Specific use Amount (¥ thousand) Scheduled spending period ① Acquisition of an interest in Delta S.r.l. and subscription for its capital increase 556,234 May 2024–June 2024 ② M&A and capital and business alliances 4,000,000 March 2024–March 2027 ③ Research and development 1,842,766 March 2024–March 2027 Total 6,399,000 －」
Of the ¥6,399,000 thousand in proceeds from the 6th Series Stock Acquisition Rights, the planned expenditure related to Delta S.r.l. has been changed to ¥556,234 thousand, and the allocation for research and development has been changed to ¥1,842,766 thousand. The ¥4,000,000 thousand allocation for M&A and capital and business alliances remains unchanged. - FY2024First statedAnnual report
「Number of stock acquisition rights issued: 40,000; potential shares underlying the issuance: 4,000,000; amount of funds raised: ¥6,399,100,000.」
On 21 March 2024, the Company issued the Sixth Series of Stock Acquisition Rights to Morgan Stanley MUFG Securities Co., Ltd. The initial exercise price was ¥1,594, the minimum exercise price was ¥1,061, and the exercise period ran from 22 March 2024 to 23 March 2027. Proceeds were intended for Delta S.r.l., M&A and capital and business alliances, and research and development.